Previous Page  10 / 16 Next Page
Information
Show Menu
Previous Page 10 / 16 Next Page
Page Background

allied

academies

Page 31

Notes:

Microbiology: Current Research | Volume 3

May 20-21, 2019 | Vienna, Austria

Medical Microbiology

4

th

International Conference on

Influenza vaccination of patients with autoimmune rheumatic disease

Stojanovich L

University Medical Center Bezanijska kosa, Serbia

Objectives:

Compared to the healthy population, patients

suffering from autoimmune rheumatic diseases have a

significantly increased risk of various infections.

Methods:

Our study includes three groups of patients (99 in

total) with stable diseases status, suffering from: 30 patients

with systemic lupus erythematosus (SLE), 37 with rheumatoid

arthritis (RA) and 32 with Sjögren's Syndrome (SjS). 46

patients were immunized with an inactivated trivalent split

vaccine (15 µg HA A/California/7/2009 (H1N1), 15 µg HA A/

Pert/16/2009 (H3N2) and 15 µg / HA B Brisbane / 60/2008)

whereas 52 patients did not accept the proposed vaccination.

These three groups of patients were divided into two

subgroups depending on vaccination: Vaccinated - SLE1 (19),

RA1 (15) and SjS1 (14), and unvaccinated - SLE2 (11), RA2 (22),

SjS2 (18). In the following six months parameters of disease

activity and the titer of antibodies against influenza A H1N1

were monitored. We used hemagglutination inhibition test

(according to the method of the Center for Disease Control

and Prevention (CDC) with antigen A/California/7/2009

influenza virus (H1N1), and turkey erythrocytes for the

detection of antibodies against the A H1N1.

Results:

The incidence of viral and bacterial infections among

vaccinated patients was significantly lower, compared to the

non-vaccinated group. Influenza occurrence was significantly

associated with previous respiratory infections (p=0.001). ST

levels for all vaccinated patients (84.17) were significantly

higher than in non-vaccinated patients (8.80) (p=0.008) and

were associated with last vaccination in all patients and in

SLE group (p=0.012, p=0.039 respectively). Seroprotective

rate for all vaccinated patients was 48% compared to 15%

in unvaccinated (p=0.014) and it was highest among SLE

patients (53%) (p= 0.049).

Conclusions:

Based on several years of monitoring respiratory

infections in our patients, it is clearly visible that a high risk

for exacerbation of the underlying disease was linked to viral

or bacterial infection and practically never to the vaccination

itself.

e

:

Ljudmila_Stojanovich@yahoo.com

Microbiol Curr Res, Volume 3

DOI: 10.4066/2591-8036-C1-006